Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Quizartinib dihydrochloride | 1132827-21-4 | 99.8% | 633.59 g·mol⁻1 | C29H34Cl2N6O4S | 5 MG
Supplier: Medchemexpress LLC HY142175MG
Quizartinib dihydrochloride is the dihydrochloride salt form of quizartinib, a second-generation, highly selective type II FLT3 tyrosine kinase inhibitor used in preclinical oncology research. It demonstrates low-nanomolar potency against FLT3 and FLT3-ITD and is employed in cellular assays and medicinal chemistry applications, including degrader design. The material is supplied at research scale with high reported purity.
- High potency FLT3 inhibition in the low-nanomolar range.
- Suitable for in vitro and preclinical AML models.
- Compatible with PROTAC linker chemistry and conjugation studies.
- Supplied as the dihydrochloride salt for improved solubility.
- High purity suitable for biochemical and cellular assays.
- Available in multiple small research pack sizes.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?